Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors (Q73540284)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

Genetic determinants of response to chemotherapy in transgenic mouse mammary and salivary tumors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Subler MA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Hundley JE

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Troyer DA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Salinas RA

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Windle JJ

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

language of work or name

English

0 references

publication date

1 February 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1114-1122

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10713698%20AND%20SRC:MED&resulttype=core&format=json

Susceptibility to apoptosis is differentially regulated by c-myc and mutated Ha-ras oncogenes and is associated with endonuclease availability

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

A Farnesyltransferase Inhibitor Induces Tumor Regression in Transgenic Mice Harboring Multiple Oncogenic Mutations by Mediating Alterations in Both Cell Cycle Control and Apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Growth factor modulation of p53-mediated growth arrest versus apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Comparative pathology of mammary tumorigenesis in transgenic mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Deficiency of p53 accelerates mammary tumorigenesis in Wnt-1 transgenic mice and promotes chromosomal instability

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Role of oncogenes in resistance and killing by cancer therapeutic agents.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Induction of apoptosis in fibroblasts by c-myc protein

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Apoptosis in cancer therapy: crossing the threshold

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

p53 mutations in human cancers

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Increased tumor proliferation and genomic instability without decreased apoptosis in MMTV-ras mice deficient in p53

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Tumor spectrum analysis in p53-mutant mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Apoptosis. Its significance in cancer and cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Induction of TNF-sensitive cellular phenotype by c-Myc involves p53 and impaired NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

p53-independent apoptosis induced by paclitaxel through an indirect mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Activated H-ras rescues E1A-induced apoptosis and cooperates with E1A to overcome p53-dependent growth arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

p53-dependent apoptosis modulates the cytotoxicity of anticancer agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Taxol: an antimitotic agent with a new mechanism of action

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Kinetics of mitotic arrest and apoptosis in murine mammary and ovarian tumors treated with taxol

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

DNA strand breaks: the DNA template alterations that trigger p53-dependent DNA damage response pathways

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Constitutive expression of the c-H-ras oncogene inhibits doxorubicin-induced apoptosis and promotes cell survival in a rhabdomyosarcoma cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Genetic determinants of p53-induced apoptosis and growth arrest

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

1 reference

7 January 2021

Coexpression of MMTV/v-Ha-ras and MMTV/c-myc genes in transgenic mice: synergistic action of oncogenes in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Adriamycin and daunomycin induce programmed cell death (apoptosis) in tumour cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Adriamycin-induced DNA damage mediated by mammalian DNA topoisomerase II

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

Cell-cycle arrest versus cell death in cancer therapy

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

An information-intensive approach to the molecular pharmacology of cancer.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021

The p53 tumour suppressor gene: a mediator of a G1 growth arrest and of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1203275

7 January 2021